SynRx Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Data insights

13 November 2024

Regeneron keeps up its co-stimulatory crusade

The company’s CD38 x CD28 MAb is among recent clinical trial entrants.

Subscribe to SynRx Therapeutics